These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SSRI prescriptions and the rate of suicide. Olfson M; Shaffer D Am J Psychiatry; 2007 Dec; 164(12):1907-8; author reply 1908-10. PubMed ID: 18056247 [No Abstract] [Full Text] [Related]
5. Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box. Lineberry TW; Bostwick JM; Beebe TJ; Decker PA Mayo Clin Proc; 2007 Apr; 82(4):518-20. PubMed ID: 17418083 [No Abstract] [Full Text] [Related]
6. The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. Leon AC Am J Psychiatry; 2007 Dec; 164(12):1786-9. PubMed ID: 18056231 [No Abstract] [Full Text] [Related]
8. [Antidepressants and suicide -- did the FDA Black Box Warning back fire?]. Rihmer Z Psychiatr Hung; 2014; 29(3):252-6. PubMed ID: 25411222 [No Abstract] [Full Text] [Related]
9. Congress investigates FDA's handling of antidepressant safety information. Young D Am J Health Syst Pharm; 2004 Nov; 61(21):2228, 2230, 2232 passim. PubMed ID: 15552624 [No Abstract] [Full Text] [Related]
10. Antidepressants and suicide. The history of a controversy--and where it stands today. Harv Ment Health Lett; 2007 Jul; 24(1):1-4. PubMed ID: 17663067 [No Abstract] [Full Text] [Related]
12. Teen suicide pills? An FDA panel calls for tough labels on antidepressants. What it means for you. Gorman C Time; 2004 Sep; 164(13):77. PubMed ID: 15478737 [No Abstract] [Full Text] [Related]
13. Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings. Lacy BW; Baron DA; Goin MK; Gross LS; Slaby AE; Sumner CR J Am Osteopath Assoc; 2013 Feb; 113(2):117-9. PubMed ID: 23412671 [No Abstract] [Full Text] [Related]
14. Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. Barbui C; Cipriani A; Geddes JR Evid Based Ment Health; 2008 May; 11(2):34-5. PubMed ID: 18441126 [No Abstract] [Full Text] [Related]
15. FDA warns about fraudulent STD treatments. AIDS Patient Care STDS; 2008 Apr; 22(4):353. PubMed ID: 18434953 [No Abstract] [Full Text] [Related]
16. Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression. Cohan JA J Contemp Health Law Policy; 2003; 20(1):115-72. PubMed ID: 15067929 [No Abstract] [Full Text] [Related]
18. FDA panel seeks to balance risks in warnings for antidepressants. Kuehn BM JAMA; 2007 Feb; 297(6):573-4. PubMed ID: 17299184 [No Abstract] [Full Text] [Related]
19. Caution over antidepressants may have backfired. Wallis L Am J Nurs; 2014 Sep; 114(9):16. PubMed ID: 25166232 [TBL] [Abstract][Full Text] [Related]
20. Legal problems in psychiatric drug prescription. Appleton WS Am J Psychiatry; 1968 Jan; 124(7):877-82. PubMed ID: 5688683 [No Abstract] [Full Text] [Related] [Next] [New Search]